An optimized CYP3A4-activatable fluorogenic sensor for in situ functional imaging and multi-dimensional inhibitor assessment

Feng Zhang, Yufan Fan, Mei Luo, Jian Huang, Bei Zhao, Lin Chen, Guanghao Zhu, Yuan Xiong, Hong Lin, Chuting Xu, Xiaodi Yang, Tony D. James, Guangbo Ge

Research output: Contribution to journalArticlepeer-review

Abstract

Cytochrome P450 3A4 (CYP3A4), one of the most important drug-metabolizing enzymes, plays a pivotal role in the oxidative metabolism of a wide range of non-polar xenobiotics and endogenous substances. Deciphering the dynamic changes in CYP3A4 activity under specific physiological or pathological conditions, as well as assessing the modulatory effects of therapeutic agents on CYP3A4, requires highly-efficient and reliable tools for sensing CYP3A4 activity within complex biological matrices. Herein, an integrated strategy was adopted for developing an optimized CYP3A4-activatable fluorogenic sensor that enables in situ detection of CYP3A4 activity in living systems without the interference of P-glycoprotein (P-gp), via integrating computer-aided substrate design, drug-likeness filtering, and biochemical assays. Following screening a range of 1,8-naphthalimide derivatives, N-cyclopropylmethyl-1,8-naphthalimide (NCN) was identified as an optimized fluorogenic substrate for CYP3A4, demonstrating exceptional isoform-specificity, single metabolite formation, ultrahigh sensitivity, high binding-affinity, improved cell-membrane permeability, and favorable bio-safety profiles. Notably, both NCN and its fluorogenic metabolite (HNCN) were identified as non-substrates of P-gp, which greatly facilitated in situ functional imaging of CYP3A4 activities in living systems, such as live cells and organs. It was also found that NCN was an orally bioavailable agent, which significantly facilitated the precise assessment of CYP3A4 inhibitors across multi-dimensional biological systems, including in vitro, ex vivo, and in vivo. Collectively, this work showcases an integrated strategy for the rational engineering of isoform-specific and orally bioavailable CYP3A4-activatable fluorogenic substrates for CYP3A4, with NCN emerging as a practical and reliable CYP3A4-activatable tool for in situ imaging and inhibitor assessment.

Original languageEnglish
JournalChemical Science
Early online date23 May 2025
DOIs
Publication statusE-pub ahead of print - 23 May 2025

Bibliographical note

.

Data Availability Statement

The data supporting this article have been included as part of the ESI.

Acknowledgements

This study was supported by Natural Science Foundation of China (82273897, 82404569, 81922070), Organizational Key Research and Development Program of Shanghai University of Traditional Chinese Medicine (2023YZZ02), Shanghai Municipal Health Commission's TCM research project (2022CX005), and the State Key Laboratory of Fine Chemicals, Dalian University of Technology (KF2202 & KF2414). T. D. J. wishes to thank the University of Bath and the Open Research Fund of the School of Chemistry and Chemical Engineering, Henan Normal University (2020ZD01) for support.

Funding

All publication charges for this article have been paid for by the Royal Society of Chemistry.

ASJC Scopus subject areas

  • General Chemistry

Fingerprint

Dive into the research topics of 'An optimized CYP3A4-activatable fluorogenic sensor for in situ functional imaging and multi-dimensional inhibitor assessment'. Together they form a unique fingerprint.

Cite this